article thumbnail

Quantum Algorithms for Healthcare

HIT Consultant

The field of computational life sciences can and should invest in the development of quantum algorithms today to take advantage of the near-term improvements and long-term transformational potential of quantum technology. How to Get Started with Quantum for Health. Isabella Martinez, Lead Quantum Technologist at Booz Allen.

article thumbnail

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

HIT Consultant

Accelerating Life Sciences Research Developing a new drug is an arduous process that typically spans over a decade, involving extensive research, development and rigorous clinical trials. The result is a 10x productivity gain, novel discoveries, and ultimately, a higher success rate of preclinical programs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotia Raises $8M to Fight Infectious Diseases Powered by AI & Genomics

HIT Consultant

Launched from Jacobs Technion-Cornell Institute at Cornell Tech, and operating from their SUNY Downstate Health Sciences University-affiliated clinical (CLIA) lab at BioBAT in New York City, Biotia has built and launched numerous advanced infectious disease research and clinical products.

article thumbnail

Medable Launches Decentralized Clinical Trials Partner Network

HIT Consultant

For example, Medable and Oracle Health Sciences have developed data and workflow integrations between Medable’s eConsent, eCOA, ePRO and TeleVisit applications with Oracle’s Clinical One platform, simplifying trial deployment and providing high levels of flexibility and choice for sponsors and CROs.

article thumbnail

Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates

HIT Consultant

Ryan Pack heads up the Diversity in Clinical Research Foundation and the Science 37 global business unit that relates directly to the company’s mission of improving diverse representation in clinical trials.

article thumbnail

Spatial Omics: The Next Wave in the Biological Research Revolution

HIT Consultant

from the Harvard-MIT Division of Health Sciences and Technology. Josh co-founded Rebus Biosystems in 2018 and served as the company’s Chief Executive Officer from its founding through 2020 when he took on his current role. Josh earned his Ph.D.